Imugene just continues it's unstoppable march towards the ultimate goal - a licensing/JV or full takeover.
The HER-Vaxx trial data continues to impress the people that matter - Scientists, Medical Journalists and Pharmaceutical companies.
Great work Leslie & the team!
Ann: Prestigious Research Journal Publish HER-Vaxx Phase 1B Data, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.025(9.26%) |
Mkt cap ! $84.38M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 29.5¢ | 27.5¢ | $477.7K | 1.674M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 16916 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 338939 | 11 |
View Market Depth
| Last trade - 10.55am 28/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |